Bill Taranto

Bill Taranto, President at Merck Global Health Innovation Fund, shares insights from his extensive career in healthcare. He discusses the $600M GHI Fund's focus on investing in digital health and technology. Taranto highlights groundbreaking companies like Npower and Cure AI that are transforming clinical trials and drug discovery. He explains the strategic advantages corporate venture capital offers startups, including industry expertise and access to networks. Lastly, he provides advice for startups navigating today's challenging market.